Skip to main content
Caplight Logo









Houdini Bio

Houdini Bio

Private
CambridgeHealthcare & Life Scienceshttps://www.houdinibio.com/

Last Round

Pre Seed

Jun 19, 2026

Est. Valuation

$14M

Total Funding Raised

$2M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Houdini Bio is a biotechnology company that provides a DNA sequence design infrastructure platform, using machine learning to overcome biological barriers in genetic medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, ML Platforms

Business Model

B2B

Customer Profile

Revenue Share, Subscription SaaS

AI Layer

Infrastructure

Keywords

DNA sequence designgene silencingtherapeutic DNA engineeringgene therapycell therapyanti-silencing technologyAI drug discoverytechbiobiotech platformHUSH complexsynthetic biologysynbiocomputational biologybiopharma partnershipsCAR-T therapygenetic medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Houdini Bio Comparables

Compare Houdini Bio with similar companies based on industry and business-model similarity.

Houdini Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Form Bio
74%
Asimov
64%
Ternary Therapeutics
54%

Houdini Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJun 19, 2026

Houdini Bio Investors

Notable investors and investment history

Houdini Bio investors
InvestorRounds
SCVCPre Seed
Deep Science VenturesPre Seed
Cambridge Enterprise VenturesPre Seed
Science Creates VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 63% MoM.

  • Jun 19, 2026

    $2M round led by SCVC

Houdini Bio Filings

Explore SEC and related filing metadata, where available.

Houdini Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Houdini Bio's valuation, stock price, and market status.

Is Houdini Bio a public or private company?

Houdini Bio is a private company.

What is the current stock price of Houdini Bio?

Houdini Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Houdini Bio worth (valuation)?

Valuation information for Houdini Bio is not publicly available.

Can I buy Houdini Bio stock?

Houdini Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Houdini Bio's last funding round?

Houdini Bio's most recent funding round was Pre Seed on June 19, 2026.

Who are the main investors in Houdini Bio?

Key investors in Houdini Bio include SCVC.

Will Houdini Bio IPO soon?

No public IPO plans have been announced for Houdini Bio.

How can I track Houdini Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Houdini Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range4
Year Founded2025
Last FundingJun 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?